Crizanlizumab Pregnancy Outcomes Intensive Monitoring
NCT07554547 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13
Last updated 2026-04-28
Summary
This was a non-interventional study to evaluate pre-specified pregnancy and infant outcomes in women treated with crizanlizumab during pregnancy or within 105 days before the last menstrual period (LMP).
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Eligibility
- Min Age
- 16 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-15
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Metformin to Prevent Preterm Birth in Twin Pregnancy
NCT05412056 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)
NCT02211651 ·Status: COMPLETED
-
MIRACLE of LIFE Study
NCT06074601 ·Status: ACTIVE_NOT_RECRUITING
-
Screening for Sacral Agenesis in Offspring of Mothers With Diabetes in Pregnancy
NCT05033275 ·Status: TERMINATED
-
Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking During Pregnancy.
NCT07528664 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy
NCT05503927 ·Status: ENROLLING_BY_INVITATION
-
Absorption, Distribution, Metabolism And Excretion Study For GSK221149A
NCT00457925 ·Status: COMPLETED ·Phase: PHASE1
-
Early Screening for Gestational Diabetes Mellitus in a Low Risk Population
NCT06704035 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
NCT05703425 ·Status: RECRUITING ·Phase: PHASE2
-
Glycemic Control and Iron Status in Diabetic Pregnancies - a Study of New Markers
NCT03330951 ·Status: COMPLETED
-
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
NCT01322529 ·Status: COMPLETED
-
Rezdiffra Pregnancy and Lactation Registry
NCT07541469 ·Status: RECRUITING
-
Micronutrients in Pregnancy as a Risk Factor for Diabetes and Effects on Mother and Baby
NCT03008824 ·Status: UNKNOWN
-
Role of HbA1c in Predicting Adverse Pregnancy Outcomes
NCT06676254 ·Status: RECRUITING
-
Gestational Diabetes Mellitus (GDM) in Pregnant Women
NCT05265741 ·Status: UNKNOWN
-
Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes
NCT03215069 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis
NCT00014768 ·Status: TERMINATED
-
Primitive Immunodeficiency and Pregnancy
NCT04581460 ·Status: COMPLETED
-
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
NCT01597063 ·Status: COMPLETED
-
SMART Health Pregnancy 2 - Intervention to Reduce Anaemia and Cardiometabolic Risk During Pregnancy and in the First Year Following Birth
NCT05752955 ·Status: COMPLETED ·Phase: NA
-
Fetal Cardiac Function Parameters and HbA1c As Screening for Gestational Diabetes Mellitus
NCT05019508 ·Status: COMPLETED
-
Proteomic Assessment of Preterm Birth
NCT01371019 ·Status: COMPLETED
-
Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)
NCT00537914 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Diabetes on the Newborn
NCT00831519 ·Status: COMPLETED
-
Avalglucosidase Alfa Pregnancy Study
NCT05734521 ·Status: RECRUITING